Photo L to R: Amir Naiberg, AVC, CEO and President, UCLA Technology Development Group, Dr. Wong, Professor, UCLA School of Dentistry and Dong-Cheol Kim, CEO, Dongwoon Anatech
UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration to Advance Saliva-Based Cancer Detection Technology
Sponsored Research Agreement will provide up to $787,500 annually to support Dr. David T.W. Wong's Electric Field-Induced Release and Measurement (EFIRM) platform.
The UCLA School of Dentistry has entered a three-year sponsored research agreement with South Korean semiconductor firm Dongwoon Anatech to advance the development of UCLA’s Electric Field-Induced Release and Measurement (EFIRM) platform—a non-invasive, saliva-based technology designed to detect cancer and other diseases early.
The agreement, signed July 18 by representatives from UCLA, UCLA’s Technology Development Group, and Dongwoon Anatech, formalizes a partnership first outlined in a March 2025 memorandum of understanding. Under the terms, Dongwoon Anatech will provide up to $787,500 annually to support research led by Dr. David T.W. Wong, professor at the UCLA School of Dentistry and director of its Center for Oral/Head & Neck Oncology Research.